Nick Pizzie
Chief Financial Officer · Axsome Therapeutics, Inc.
- 2026
- Jun 9, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nick Pizzie files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- Mark L. Jacobson - $8.90M in AXSM purchases and sales in the last 12 months
- Mark Coleman - $8.21M in AXSM purchases and sales in the last 12 months
- Mark E. Saad - $6.21M in AXSM purchases and sales in the last 12 months
- Ari Maizel - $2.75M in AXSM purchases and sales in the last 12 months
- Susan Mahony - $145K in AXSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nick Pizzie?
Nick Pizzie is a corporate insider, tracked as Chief Financial Officer of Axsome Therapeutics, Inc. (AXSM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nick Pizzie last file a Form 4?
The most recent primary Form 4 on record is dated 9 June 2026, one of 4 filings going back to 2026.
Has Nick Pizzie been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($10.18M) across all tracked filings.
